Pine Valley Investments Ltd Liability Co Sells 4,009 Shares of CVS Health Co. (NYSE:CVS)

Pine Valley Investments Ltd Liability Co cut its stake in shares of CVS Health Co. (NYSE:CVS) by 19.3% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 16,742 shares of the pharmacy operator’s stock after selling 4,009 shares during the quarter. Pine Valley Investments Ltd Liability Co’s holdings in CVS Health were worth $752,000 as of its most recent SEC filing.

Other institutional investors and hedge funds have also recently modified their holdings of the company. MidAtlantic Capital Management Inc. bought a new stake in CVS Health in the 3rd quarter worth about $25,000. Ridgewood Investments LLC increased its holdings in CVS Health by 255.7% in the 4th quarter. Ridgewood Investments LLC now owns 626 shares of the pharmacy operator’s stock worth $28,000 after buying an additional 450 shares in the last quarter. Stonebridge Financial Group LLC bought a new stake in CVS Health in the 4th quarter worth about $28,000. Legacy Investment Solutions LLC bought a new stake in CVS Health in the 3rd quarter worth about $31,000. Finally, Reston Wealth Management LLC bought a new stake in CVS Health in the 3rd quarter worth about $32,000. 80.66% of the stock is currently owned by institutional investors.

CVS Health Stock Up 0.2 %

NYSE CVS opened at $63.78 on Thursday. The stock’s 50 day moving average is $53.48 and its 200 day moving average is $56.34. The company has a current ratio of 0.81, a quick ratio of 0.60 and a debt-to-equity ratio of 0.80. CVS Health Co. has a 12 month low of $43.56 and a 12 month high of $80.75. The stock has a market cap of $80.42 billion, a PE ratio of 17.43, a P/E/G ratio of 0.98 and a beta of 0.61.

CVS Health (NYSE:CVS) last posted its quarterly earnings results on Wednesday, February 12th. The pharmacy operator reported $1.19 EPS for the quarter, topping analysts’ consensus estimates of $0.89 by $0.30. CVS Health had a return on equity of 9.11% and a net margin of 1.24%. Research analysts predict that CVS Health Co. will post 5.89 EPS for the current fiscal year.

CVS Health Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Monday, February 3rd. Investors of record on Thursday, January 23rd were issued a $0.665 dividend. The ex-dividend date of this dividend was Thursday, January 23rd. This represents a $2.66 dividend on an annualized basis and a yield of 4.17%. CVS Health’s dividend payout ratio is presently 72.68%.

Insider Buying and Selling

In other news, Director Michael F. Mahoney acquired 30,000 shares of CVS Health stock in a transaction on Tuesday, February 18th. The shares were acquired at an average price of $66.70 per share, with a total value of $2,001,000.00. Following the purchase, the director now directly owns 39,356 shares in the company, valued at $2,625,045.20. The trade was a 320.65 % increase in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. 0.24% of the stock is owned by insiders.

Analysts Set New Price Targets

Several research firms recently commented on CVS. Wells Fargo & Company raised their target price on CVS Health from $68.00 to $73.00 and gave the stock an “overweight” rating in a research report on Thursday, February 13th. Truist Financial raised their target price on CVS Health from $60.00 to $76.00 and gave the stock a “buy” rating in a research report on Thursday, February 13th. Edward Jones raised CVS Health from a “hold” rating to a “buy” rating in a research report on Thursday, January 30th. TD Cowen raised their target price on CVS Health from $73.00 to $80.00 and gave the stock a “buy” rating in a research report on Monday, November 25th. Finally, Barclays raised their target price on CVS Health from $71.00 to $73.00 and gave the stock an “overweight” rating in a research report on Thursday, February 13th. Four research analysts have rated the stock with a hold rating, seventeen have given a buy rating and one has given a strong buy rating to the company. Based on data from MarketBeat, the stock has an average rating of “Moderate Buy” and an average target price of $70.00.

CVS Health Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.